NCT05966753View on ClinicalTrials.gov

Describing Patient With DME, Their Patient Journey and Disease Progression

CompletedOBSERVATIONAL
Enrollment

221,004

Participants

Timeline

Start Date

August 3, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Diabetic Macular Edema
Trial Locations (1)

02451

CorEvitas HQ, Waltham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05966753 - Describing Patient With DME, Their Patient Journey and Disease Progression | Biotech Hunter | Biotech Hunter